These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 36173594)

  • 1. Do ART and Chemsex Drugs Get Along? Potential Drug-Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study.
    De La Mora L; Nebot MJ; Martinez-Rebollar M; De Lazzari E; Tuset M; Laguno M; Ambrosioni J; Miquel L; Blanch J; Ugarte A; Torres B; González-Cordón A; Inciarte A; Chivite I; Short D; Salgado E; Martinez E; Blanco JL; Mallolas J
    Infect Dis Ther; 2022 Dec; 11(6):2111-2124. PubMed ID: 36173594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study.
    Altunal LN; Yagcı Caglayık D; Ozel AS; Tukenmez Tigen E; Sili U; Erturk Sengel B; Aydın M; Korten V
    AIDS Patient Care STDS; 2023 Mar; 37(3):138-145. PubMed ID: 36812461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain.
    Castro-Granell V; Garin N; Jaén Á; Cenoz S; Galindo MJ; Fuster-RuizdeApodaca MJ
    PLoS One; 2021; 16(11):e0260334. PubMed ID: 34797882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study.
    Marzolini C; Elzi L; Gibbons S; Weber R; Fux C; Furrer H; Chave JP; Cavassini M; Bernasconi E; Calmy A; Vernazza P; Khoo S; Ledergerber B; Back D; Battegay M;
    Antivir Ther; 2010; 15(3):413-23. PubMed ID: 20516560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential drug-drug interactions in the era of integrase strand transfer inhibitors: a cross-sectional single-center study in Japan.
    Kunimoto Y; Matamura R; Ikeda H; Fujii S; Kimyo T; Kitagawa M; Nakata H; Kobune M; Miyamoto A; Fukudo M
    J Pharm Health Care Sci; 2021 Dec; 7(1):43. PubMed ID: 34847955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team.
    Molas E; Luque S; Retamero A; Echeverría-Esnal D; Guelar A; Montero M; Guerri R; Sorli L; Lerma E; Villar J; Knobel H
    HIV Clin Trials; 2018 Feb; 19(1):1-7. PubMed ID: 29179644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing emergency department admissions for chemsex-related intoxications in Barcelona, Spain, among people living with HIV: an observational study from 2018 to 2020.
    Vallecillo G; Losada A; Inciarte A; Jiwei C; Monterde A; Salgado E; Doi AL; Monclus E; Perelló R
    BMC Public Health; 2022 Feb; 22(1):346. PubMed ID: 35180855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
    Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Potential Drug-Drug Interactions in Patients of the Swiss HIV Cohort Study in the Era of HIV Integrase Inhibitors.
    Deutschmann E; Bucher HC; Jaeckel S; Gibbons S; McAllister K; Scherrer AU; Braun DL; Cavassini M; Hachfeld A; Calmy A; Battegay M; Cipriani M; Elzi L; Young J; Lopez-Centeno B; Berenguer J; Khoo S; Moffa G; Marzolini C;
    Clin Infect Dis; 2021 Oct; 73(7):e2145-e2152. PubMed ID: 32634832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual behavior and drug use impact in gay, bisexual, and other men who have sex with men.
    García-Pérez JN; Cañas-Ruano E; Navarro J; Raventós B; López L; Broto C; Arando M; Barberá MJ; Descalzo V; Suanzes P; Burgos J; Curran A; Falcó V
    Med Clin (Barc); 2022 Dec; 159(12):563-568. PubMed ID: 35725636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients.
    Tseng A; Szadkowski L; Walmsley S; Salit I; Raboud J
    Ann Pharmacother; 2013 Nov; 47(11):1429-39. PubMed ID: 24285760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Prevalence of Drug-Drug Interactions with Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Patients in the Intensive Care Unit.
    Johnston JP; Heavner MS; Liu M; Casal GLH; Akgün KM
    J Pharm Pract; 2023 Apr; 36(2):322-328. PubMed ID: 34587846
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential drug-drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey.
    Tinggaard M; David KP; Gerstoft J; Hansen AE; Kirk O; Lebech AM; Lindhardt BØ; Rose MV; Ryom L; Weis N; Benfield T
    HIV Med; 2023 Jan; 24(1):46-54. PubMed ID: 35521975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemsex and antiretroviral prescribing in an HIV cohort in Brighton, UK.
    Adler Z; Fitzpatrick C; Broadwell N; Churchill D; Richardson D
    HIV Med; 2022 Aug; 23(7):797-800. PubMed ID: 35048490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between use of chemsex drugs and HIV clinic attendance among gay and bisexual men living with HIV in London.
    Howarth AR; Apea V; Michie S; Morris S; Sachikonye M; Mercer CH; Evans A; Delpech VC; Sabin C; Burns FM
    HIV Med; 2021 Sep; 22(8):641-649. PubMed ID: 33949070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan.
    Ismail M; Iqbal Z; Khattak MB; Khan MI; Arsalan H; Javaid A; Gul Q; Khan F
    Int J Clin Pharm; 2013 Jun; 35(3):455-62. PubMed ID: 23483444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Drug-Related Problems in Chronic Kidney Disease Patients.
    Shouqair TM; Rabbani SA; Sridhar SB; Kurian MT
    Cureus; 2022 Apr; 14(4):e24019. PubMed ID: 35573572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda.
    Eneh PC; Hullsiek KH; Kiiza D; Rhein J; Meya DB; Boulware DR; Nicol MR
    BMC Infect Dis; 2020 Aug; 20(1):572. PubMed ID: 32758158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly drug use, chemsex drug use, and associations with sexual risk behaviour in HIV-negative men who have sex with men attending sexual health clinics.
    Sewell J; Miltz A; Lampe FC; Cambiano V; Speakman A; Phillips AN; Stuart D; Gilson R; Asboe D; Nwokolo N; Clarke A; Collins S; Hart G; Elford J; Rodger AJ;
    Int J Drug Policy; 2017 May; 43():33-43. PubMed ID: 28189979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemsex among gay, bisexual, and other men who have sex with men in Singapore and the challenges ahead: A qualitative study.
    Tan RKJ; Wong CM; Chen MI; Chan YY; Bin Ibrahim MA; Lim OZ; Chio MT; Wong CS; Chan RKW; Chua LJ; Choong BCH
    Int J Drug Policy; 2018 Nov; 61():31-37. PubMed ID: 30388567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.